Biomarkers of neurological and psychiatric disease / (Record no. 534771)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06987cam a2200505Ia 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn770599299 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20180529115151.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 111129s2011 ne a ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780123877239 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0123877237 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780123877185 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0123877180 |
| Qualifying information | (electronic bk.) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)770599299 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DLC |
| Language of cataloging | eng |
| Transcribing agency | DLC |
| Modifying agency | AU |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | Alfaisal Main Library |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC376.5 |
| 245 00 - TITLE STATEMENT | |
| Title | Biomarkers of neurological and psychiatric disease / |
| Statement of responsibility, etc | edited by Paul C. Guest and Sabine Bahn. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Amsterdam : |
| Name of publisher, distributor, etc | Elsevier, |
| Date of publication, distribution, etc | 2011. |
| 264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS | |
| Date of production, publication, distribution, manufacture | 2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xx, 450 pages) : |
| Other physical details | illustrations. |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | International review of neurobiology, |
| International Standard Serial Number | 0074-7742 ; |
| Volume number/sequential designation | vol. 101 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia. Leading authors review state-of-the-art in their field of investigation and provide their views and perspectives for future research Chapters are extensively referenced to provide readers with a comprehensive list of resources on the topics covered All chapters include comprehensive background information and are written in a clear form that is also accessible to the non-specialist. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | General overview: biomarkers in neuroscience research -- Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands -- The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders -- Proteomic technologies for biomarker studies in psychiatry: advances and needs -- Converging evidence of blood-based biomarkers for schizophrenia: an update -- Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia -- Immune and neuroimmune alterations in mood disorders and schizophrenia -- Behavioral and molecular biomakers in translational animal models for neuropsychiatric disorders -- Stem cell models for biomarker discovery in brain disease -- The application of multiplexed assay systems for molecular diagnostics -- Algorithm development for diagnostic biomarker assays -- Challenges of introducing new biomarker products for neuropsychiatric disorders into the market -- Toward personalized medicine in the neuropsychiatric field -- Clinical utility of serum biomarkers for major psychiatric disorders -- The future: biomarkers, biosensors, neuroinformatics, and E-neuropsychiatry -- |
| 505 00 - FORMATTED CONTENTS NOTE | |
| Title | Biomarkers of Neurological and Psychiatric Disease -- |
| -- | Contributors -- |
| Miscellaneous information | 1. |
| Title | : General Overview: Biomarkers in Neuroscience Research -- |
| -- | I. The Quest for Biomarkers in Neuroscience -- |
| -- | A. Biomarkers in Clinical Practice -- |
| -- | B. Biomarkers for the Development of Novel Therapeutics and in Basic Research -- |
| -- | II. Tools for Biomarker Discovery in Neuroscience -- |
| -- | III. Advancements in Biomarker Discovery in Neuroscience -- |
| -- | A. Mouse Models -- |
| -- | B. Human Data -- |
| Miscellaneous information | 1. |
| Title | Postmortem Brain Tissue Studies -- |
| Miscellaneous information | 2. |
| Title | Cerebrospinal Fluid Studies -- |
| Miscellaneous information | 3. |
| Title | Plasma Studies -- |
| -- | C. Future Directions -- |
| -- | IV. Considerations for Biomarker Discovery and Translation in NeuroscienceA. Disease Complexity -- |
| -- | B. Sample Quality and Collection -- |
| -- | C. Candidate Biomarker Validation -- |
| -- | D. Systemic Approaches and Biomarker Initiatives -- |
| -- | V. Outlook-The Perspective of Personalized Medicine -- |
| Miscellaneous information | 2. |
| Title | : Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands -- |
| -- | I. Introduction -- |
| -- | II. Principles of PET Imaging -- |
| -- | III. TSPO for Assessment of Microglial Expression -- |
| -- | IV. Challenges Facing PET Imaging of the TSPO -- |
| -- | V. Disease Applications -- |
| -- | A. Neuroinflammatory DiseasesB. Neurodegenerative Diseases -- |
| -- | C. Movement Disorders -- |
| Miscellaneous information | 1. |
| Title | Parkinson's Disease -- |
| Miscellaneous information | 2. |
| Title | Huntington's Disease -- |
| -- | D. Stroke -- |
| -- | E. Neuropsychiatric Diseases -- |
| -- | VI. Conclusion -- |
| Miscellaneous information | 3. |
| Title | : The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders -- |
| -- | I. Introduction -- |
| -- | II. Microarray Gene Expression Analysis -- |
| -- | III. Diagnostic Gene Expression Classifiers -- |
| -- | IV. Blood Gene Expression Studies of Neuropsychiatric Disorders -- |
| -- | V. MicroRNA Expression Analysis -- |
| -- | VI. Pharmacogenomics -- |
| -- | VII. Concluding Remarks -- |
| Miscellaneous information | 4. |
| Title | : Proteomic technologies for biomarker studies in psychiatry: Advances and NeedsI. Introduction -- |
| -- | II. The Social Impact of Psychiatric Disorders -- |
| -- | III. The Role of Proteomics in Psychiatry -- |
| -- | A. What Has Been Done So Far? -- |
| -- | IV Proteomic Studies in Psychiatry: What Methods Have Been Used to Date? -- |
| -- | A Sample Preparation -- |
| -- | B Two-Dimensional Gel Electrophoresis and Mass Spectrometry -- |
| -- | C Shotgun Proteomics -- |
| Miscellaneous information | 1. |
| Title | Label-Free MS -- |
| Miscellaneous information | 2. |
| Title | Stable Isotope Labeling -- |
| Miscellaneous information | 3. |
| Title | In Vivo Labeling -- |
| -- | D SELDI-TOF -- |
| -- | E Metabolomics -- |
| -- | F Multiplex Analyte Profiling Approach -- |
| -- | G What Is the Best Method for Proteome Characterization? -- |
| -- | V Underexplored Proteomic Methods in Psychiatry StudiesA Phosphoproteomics -- |
| -- | B SILAC -- |
| -- | C MALDI Imaging -- |
| -- | VI. The Importance of Validation Experiments in Proteomics for Biomarker Discovery in Psychiatry -- |
| -- | A. Validation Technologies -- |
| Miscellaneous information | 1. |
| Title | Selective Reaction Monitoring -- |
| Miscellaneous information | 2. |
| Title | ELISA -- |
| Miscellaneous information | 3. |
| Title | Western Blot -- |
| Miscellaneous information | 4. |
| Title | Functional Genomics -- |
| Miscellaneous information | 5. |
| Title | Tissue Microarray -- |
| Miscellaneous information | 6. |
| Title | Protein Arrays -- |
| -- | VII. Clinical Translation -- |
| -- | VIII. Summary -- |
| Miscellaneous information | 5. |
| Title | : Converging evidence of blood-based biomarkers for schizophrenia: An Update -- |
| -- | I. Introduction -- |
| -- | II. Methodology -- |
| -- | A. Compilation of Literature Serum/Plasma Biomarkers -- |
| -- | B. Compilation of In-House Serum Biomarkers. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Elsevier |
| Provenance (VM) [OBSOLETE] | ScienceDirect All Books |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuropsychiatry. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | HEALTH & FITNESS |
| General subdivision | Diseases |
| -- | Alzheimer's & Dementia. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Neurology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurology. |
| Source of heading or term | fast |
| -- | (OCoLC)fst01036390 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuropsychiatry. |
| Source of heading or term | fast |
| -- | (OCoLC)fst01036481 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| Source of heading or term | fast |
| -- | (OCoLC)fst01081152 |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | local |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guest, Paul C., |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bahn, Sabine, |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | ScienceDirect eBooks. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | International review of neurobiology ; |
| Volume number/sequential designation | v. 101. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://ezproxy.alfaisal.edu/login?url=https://www.sciencedirect.com/science/bookseries/00747742/101">http://ezproxy.alfaisal.edu/login?url=https://www.sciencedirect.com/science/bookseries/00747742/101</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | eBooks |
No items available.